Fred Alger Management LLC increased its position in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 3.1% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 30,935 shares of the biotechnology company’s stock after purchasing an additional 930 shares during the period. Fred Alger Management LLC’s holdings in Axon Enterprise were worth $12,362,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AXON. Blue Trust Inc. grew its holdings in shares of Axon Enterprise by 987.5% during the second quarter. Blue Trust Inc. now owns 87 shares of the biotechnology company’s stock valued at $27,000 after buying an additional 79 shares in the last quarter. Quent Capital LLC boosted its position in Axon Enterprise by 1,875.0% during the 3rd quarter. Quent Capital LLC now owns 79 shares of the biotechnology company’s stock worth $32,000 after acquiring an additional 75 shares during the period. Brooklyn Investment Group purchased a new position in Axon Enterprise during the 3rd quarter valued at about $41,000. Asset Dedication LLC acquired a new position in shares of Axon Enterprise in the 2nd quarter valued at about $47,000. Finally, Planning Capital Management Corp lifted its position in shares of Axon Enterprise by 83.3% in the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. 79.08% of the stock is currently owned by hedge funds and other institutional investors.
Insider Activity at Axon Enterprise
In other Axon Enterprise news, President Joshua Isner sold 20,000 shares of the company’s stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Jeffrey C. Kunins sold 21,834 shares of Axon Enterprise stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares in the company, valued at $91,691,508.72. The trade was a 12.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 210,256 shares of company stock worth $87,783,120. 6.10% of the stock is owned by insiders.
Axon Enterprise Trading Up 1.9 %
Wall Street Analyst Weigh In
A number of research analysts recently commented on AXON shares. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $440.00 to $460.00 and gave the company an “outperform” rating in a research report on Monday, November 4th. Barclays increased their price objective on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Northland Securities boosted their target price on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Craig Hallum raised their price target on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a research note on Wednesday, August 7th. Finally, JMP Securities boosted their price target on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. Two research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $427.83.
Check Out Our Latest Stock Report on AXON
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Read More
- Five stocks we like better than Axon Enterprise
- 3 Grocery Stocks That Are Proving They Are Still Essential
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- How to Use High Beta Stocks to Maximize Your Investing Profits
- 3 Penny Stocks Ready to Break Out in 2025
- Find and Profitably Trade Stocks at 52-Week Lows
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.